Financial Performance - For the fiscal year ending September 30, 2024, the group's revenue increased by approximately 0.7% to about HKD 983,200,000, primarily driven by the beauty services business [3]. - The group reported a net profit of HKD 68,100,000, a decrease of 38.2% compared to the previous fiscal year [5]. - The total comprehensive income for the year was HKD 70,136,000, compared to HKD 109,580,000 last year, indicating a decline of 36.0% [11]. - Basic and diluted earnings per share were both HKD 0.10, down from HKD 0.162 in the previous year, representing a decrease of 38.3% [11]. - The company's profit for the fiscal year 2024 is projected to be HKD 68,285,000, a decrease from HKD 110,320,000 in fiscal year 2023 [38]. Revenue Breakdown - The company's revenue for the year ending September 30, 2024, was HKD 983,215,000, an increase of 0.7% compared to HKD 976,572,000 for the previous year [9]. - Skincare product sales for 2024 were HKD 130,071,000, down from HKD 152,815,000 in 2023, indicating a decline of about 15% [26]. - The service segment, which includes beauty treatments and medical services, generated revenue of HKD 853,144,000 in 2024, compared to HKD 823,757,000 in 2023, reflecting an increase of approximately 3.8% [26]. - Revenue from Hong Kong and Macau was HKD 922,614,000 in 2024, compared to HKD 904,363,000 in 2023, marking an increase of approximately 2.4% [31]. - Revenue from mainland China decreased to HKD 60,601,000 in 2024 from HKD 72,209,000 in 2023, a decline of about 16.1% [31]. Profitability and Costs - The group's gross profit margin improved from 90.2% to 91.6% year-on-year, attributed to strong performance in major beauty service brands [3]. - The gross profit margin decreased, with cost of goods sold at HKD 83,022,000 compared to HKD 95,653,000 last year, reflecting a reduction in inventory purchases [9]. - The operating profit for the overall business in 2024 was HKD 231,430,000, slightly up from HKD 229,760,000 in 2023, showing a marginal growth of about 0.7% [26]. - The total financing costs for 2024 were HKD 9,174,000, slightly higher than HKD 9,032,000 in 2023, representing an increase of about 1.6% [31]. Dividends and Shareholder Returns - The group recommends a final dividend of HKD 0.02 per share [5]. - The interim dividend declared is HKD 3.5 cents per share for fiscal year 2024, down from HKD 7.0 cents per share in fiscal year 2023, totaling approximately HKD 23,819,000 [40]. - The total amount of dividends paid as of September 30, 2024, is approximately HKD 71,458,000, compared to HKD 98,680,000 in fiscal year 2023 [41]. - The board proposed a final dividend of HKD 0.02 per share for the year ending September 30, 2024, subject to approval at the upcoming annual general meeting [73]. Operational Insights - The group operates a total of 51 beauty service outlets in Hong Kong, 2 in Macau, and 3 in mainland China [5]. - The number of employees has decreased from 1,073 to 914 following the closure of some stores [49]. - The group continues to streamline and adjust retail brand outlets, resulting in a decrease in the number of operational outlets by year-end [62]. - The group launched several new products and treatments, including the "Poland Royal" biotechnology treatment and various body sculpting therapies, contributing to stable performance [54]. Financial Position - The company's total assets decreased to HKD 620,073,000 from HKD 796,604,000, a decline of 22.1% year-over-year [13]. - Cash and cash equivalents increased significantly to HKD 485,156,000 from HKD 271,764,000, showing a growth of 78.5% [13]. - The company's total liabilities increased to HKD 830,732,000 from HKD 735,448,000, reflecting a rise of 12.9% [15]. - The capital debt ratio as of September 30, 2024, remains at zero, consistent with the previous year [67]. Market and Strategic Focus - The group plans to maintain a proactive approach and focus on providing high-quality beauty services and products, while continuing to invest in the latest beauty equipment and technology [7]. - The group aims to further reduce risks associated with the current market situation and closely monitor profitability and new customer trends [7]. - The group is satisfied with its performance over the past twelve months but acknowledges ongoing severe challenges in the Hong Kong market, with no assurance of maintaining good performance in the coming months [63]. - The group remains committed to maintaining a debt-free financial position, thus avoiding the burden of high-interest costs from previous years [63]. Accounting and Compliance - The group has adopted new accounting standards and amendments issued by the Hong Kong Institute of Certified Public Accountants, which did not have a significant impact on the financial position and performance for the current and prior years [18]. - The revised Hong Kong Financial Reporting Standards require the disclosure of significant accounting policy information, which may reasonably be expected to influence the decisions of primary users of the financial statements [19]. - The independent auditor has confirmed that the financial statements are consistent with the audited consolidated financial statements for the year ending September 30, 2024 [78].
奥思集团(01161) - 2024 - 年度业绩